JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.12% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 8.72% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Quanta Services
PWR
$103B
| $3.96M | ﹤0.01% |
97,143
-2,831
| -3% | -$116K |
|
|
MMP
2752
PUT
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $3.96M | ﹤0.01% |
+62,900
| New | +$3.92M |
|
2753
PUT
Constellation Brands
STZ
$23.3B
| $3.95M | ﹤0.01% |
20,800
| – | – |
|
|
CRHM
2754
DELISTED
CRH Medical Corporation
CRHM
| $3.94M | ﹤0.01% |
1,135,653
+53,700
| +5% | +$169K |
|
2755
Camden National
CAC
$998M
| $3.94M | ﹤0.01% |
85,555
+18,677
| +28% | +$825K |
|
2756
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
| $3.93M | ﹤0.01% |
114,321
+2,331
| +2% | +$76.5K |
|
|
TUFN
2757
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $3.92M | ﹤0.01% |
222,804
-119,373
| -35% | -$2.04M |
|
2758
CALL
C.H. Robinson
CHRW
$17.4B
| $3.91M | ﹤0.01% |
+50,000
| New | +$3.98M |
|
2759
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.45B
| $3.91M | ﹤0.01% |
90,660
-13,838
| -13% | -$572K |
|
2760
Star Bulk Carriers
SBLK
$3.22B
| $3.9M | ﹤0.01% |
330,521
+222,777
| +207% | +$2.41M |
|
2761
Donnelley Financial Solutions
DFIN
$1.22B
| $3.9M | ﹤0.01% |
372,599
-241,817
| -39% | -$2.53M |
|
2762
CALL
Dollar General
DG
$27.2B
| $3.9M | ﹤0.01% |
25,000
| – | – |
|
|
2763
PUT
Dollar General
DG
$27.2B
| $3.9M | ﹤0.01% |
25,000
| – | – |
|
2764
Cleveland-Cliffs
CLF
$7.01B
| $3.9M | ﹤0.01% |
463,901
+26,570
| +6% | +$204K |
|
2765
PUT
Howmet Aerospace
HWM
$113B
| $3.89M | ﹤0.01% |
164,826
+135,486
| +462% | +$3.03M |
|
|
MRSN
2766
DELISTED
Mersana Therapeutics
MRSN
| $3.89M | ﹤0.01% |
27,130
-10,027
| -27% | -$733K |
|
2767
Matador Resources
MTDR
$6.51B
| $3.88M | ﹤0.01% |
215,691
-864
| -0.4% | -$12.9K |
|
2768
Carpenter Technology
CRS
$26.9B
| $3.88M | ﹤0.01% |
77,846
+699
| +0.9% | +$35.9K |
|
2769
Vanguard Morningstar Small-Cap Growth ETF
VBK
$25B
| $3.87M | ﹤0.01% |
19,498
+921
| +5% | +$175K |
|
2770
Ambarella
AMBA
$3.63B
| $3.87M | ﹤0.01% |
63,837
+14,059
| +28% | +$779K |
|
|
BBBY
2771
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.85M | ﹤0.01% |
222,731
+47,086
| +27% | +$659K |
|
2772
Beyond Meat
BYND
$6.69B
| $3.85M | ﹤0.01% |
1,698
+1,625
| +2,226% | +$4.52M |
|
2773
PUT
Medtronic
MDT
$116B
| $3.85M | ﹤0.01% |
33,900
+30,000
| +769% | +$3.29M |
|
2774
Eagle Bancorp
EGBN
$880M
| $3.85M | ﹤0.01% |
79,064
-37,458
| -32% | -$1.7M |
|
2775
First Merchants
FRME
$2.72B
| $3.85M | ﹤0.01% |
92,458
+18,068
| +24% | +$721K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.